Kimia Biosciences Ltd Share Price Today - Kimia Biosciences Ltd Stock Price Live NSE/BSE

Kimia Biosciences Ltd

NSE: BSE: 530313

₹33.69

(0%)

Wed, 04 Mar 2026, 08:46 pm

MTF 5xInvest in Kimia Biosciences Ltd with 5x Leverage Buy with MTF

Market Cap1.59B

PE Ratio17.61

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Kimia Biosciences Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
149.13
Net Profit
9.61
P/B
20.15
Sector P/E
40.46
P/E
20.94
EV/EBITDA
10.82
Debt/Equity (Industry)
0.16
Interest Cover (Industry)
20.20
ROCE (Industry)
20.50
RONW (Industry)
17.60
ROE
172.53
ROCE
34.57
Debt/Equity
7.46
EPS (TTM)
1.91
Dividend Yield
0
Book Value
2.45
Interest Cover
3.99

Analysis

all

Pros

Kimia Biosciences is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Kimia Biosciences is profitable, therefore cash runway is not a concern.
Kimia Biosciences is profitable, therefore cash runway is not a concern.
Debt is covered by short term assets, assets are 1.8x debt.
Kimia Biosciences's cash and other short term assets cover its long term commitments.

Cons

Unable to evaluate Kimia Biosciences's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
Unable to evaluate Kimia Biosciences's dividend against the top 25% market benchmark as the company has not reported any payouts.
Operating cash flow is negative therefore debt is not well covered.
The level of debt compared to net worth has increased over the past 5 years (100.2% vs 230.4% today).
Interest payments on debt are not well covered by earnings (EBIT is 2.3x annual interest expense, ideally 3x coverage).

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	74.94	74.94	74.94	74.94	74.94
FII	0	0	0	0	0
DII	0.38	0.38	0.38	0.38	0.38
Public	24.68	24.68	24.68	24.68	24.68
Government	0	0	0	0	0

Technical Analysis

RSI

44.11

MACD

-0.04

50 DMA

32.31

200 DMA

40.56

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	63.02	49.26	41.47	35.50	27.71	21.74	7.98
Fibonacci	49.26	44.00	40.75	35.50	30.24	26.99	21.74
Camarilla	37.47	36.21	34.95	35.50	32.43	31.17	29.91

Pivots Level: Classic

+27.52

63.02

+13.76

49.26

+5.98

41.47

35.50

Pivot Point

LTP: 30.35

-7.78

27.71

-13.76

21.74

-27.52

7.98

Moving Average

SMAEMA

Period

Value

10-EMA
32.49
20-EMA
32.69
30-EMA
32.60
50-EMA
32.56
100-EMA
33.92
200-EMA
37.38

Announcement Date	Purpose	Action
14 Feb 2026	board-meetings	Quarterly Results, Nine Months Results
14 Nov 2025	board-meetings	Quarterly Results
29 Aug 2025	agm
25 Jun 2025	egm
05 Dec 2024	agm
02 Sept 2023	agm
23 Sept 2022	agm
28 Aug 2021	agm

Kimia Biosciences Ltd

Torrent Pharmaceuticals Ltd

Divis Laboratories Ltd

Cipla Ltd

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd

Kimia Biosciences Ltd About

Kimia Biosciences main objective of the Company is to carry on business of Pharamaceutical products.

Industry

Pharmaceuticals - Indian - Bulk Drugs

Founded

1993

Headquarters

CEO

Sameer Goel

Employees

Contact

Website

http://www.kimiabiosciences.com

compliance.kimia@gmail.com

Phone

91-11-29535650

Location

Bhondsi Village, Tehsil Sohna, Gurgaon, Haryana, 122102

Year	History
1993	Laurel Organics Ltd. was incorporated in district Gurgaon, Haryana, India.
2017	NCLT approved the Scheme of Arrangement for Amalgamation of Kimia Biosciences Limited with Laurel Organics Limited
2019	The company name was changed to Kimia Biosciences Ltd. from Laurel Organics Ltd.
2024	Kimia Biosciences Limited was awarded a contract by a European client worth USD 200,000.

Client Name	Order Side	QTY	Avg Price	Date
No Result Found

Kimia Biosciences Ltd News

Kimia Biosciences Director Resigns Due to Personal Reasons

Mr. Kaku Vijaya Shekhar Reddy, Additional Director at Kimia Biosciences Limited, resigned from his executive position effective February 18, 2026, citing personal reasons for his departure.

19 Feb 2026

stocks

Kimia Biosciences Board Approves Q3FY26 Results

Kimia Biosciences Limited board approved Q3FY26 unaudited financial results and re-appointed Sameer Goel as Managing Director for five years. Board also approved postal ballot notice for shareholder approvals.

14 Feb 2026

co actions results

Kimia Biosciences Gets Patent for Luliconazole Process

Kimia Biosciences Limited receives 20-year patent from Government of India for improved process of preparing antifungal API Luliconazole, strengthening its intellectual property portfolio.

10 Feb 2026

stocks

Kimia Biosciences Board Meet on Feb 14 for Q3 Results

Kimia Biosciences Limited has scheduled a board meeting for February 14, 2026, to consider Q3FY26 unaudited financial results and re-appointment of Managing Director Sameer Goel for five years.

07 Feb 2026

co actions results

Kimia Biosciences CFO Naveen Sharma Resigns

Kimia Biosciences Limited announces resignation of Chief Financial Officer Mr. Naveen Sharma effective February 2, 2026, citing personal reasons for departure from key managerial position.

02 Feb 2026

stocks

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800